Real world utilization of Andexanet Alfa at a community hospital

Factor Xa inhibitors have been shown to be effective in the treatment and prevention of venous thromboembolism and the prevention of ischemic cerebral vascular accidents in those with atrial fibrillation [1-4]. However, acute and life-threatening hemorrhage has been associated with their use and can cause significant morbidity and mortality [ 1-4]. With the increasing use of the factor Xa inhibitors, the number of patients who may potentially need reversal of their anticoagulation due to life-threatening hemorrhage is expected to increase over the next several years.
Source: The American Journal of Emergency Medicine - Category: Emergency Medicine Authors: Source Type: research